as 10-04-2024 4:00pm EST
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Founded: | 1989 | Country: | United States |
Employees: | N/A | City: | PRINCETON |
Market Cap: | 1.3B | IPO Year: | 1995 |
Target Price: | $30.44 | AVG Volume (30 days): | 1.0M |
Analyst Decision: | Hold | Number of Analysts: | 9 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.30 | EPS Growth: | -81.21 |
52 Week Low/High: | $16.81 - $45.42 | Next Earning Date: | 10-23-2024 |
Revenue: | $1,566,507,000 | Revenue Growth: | 1.37% |
Revenue Growth (this year): | 6.71% | Revenue Growth (next year): | 6.20% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Mosebrook Jeffrey | IART | SVP, Fin & Princ Acct Officer | Aug 19 '24 | Sell | $21.58 | 1,191 | $25,700.83 | 36,088 |
IART Breaking Stock News: Dive into IART Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Argus Research
6 days ago
Zacks
7 days ago
Simply Wall St.
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
Argus Research
2 months ago
The information presented on this page, "IART Integra LifeSciences Holdings Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.